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This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).SUMMARYSelf-renewal potential and multipotency are hallmarks of a stem cell. It is generally accepted that acquisition of such stemness requires
rejuvenation of somatic cells through reprogramming of their genetic and epigenetic status.We show here that a simple block of cell dif-
ferentiation is sufficient to induce andmaintain stem cells. By overexpression of the transcriptional inhibitor ID3 in murine hematopoi-
etic progenitor cells and cultivation under B cell induction conditions, the cells undergo developmental arrest and enter a self-renewal
cycle. These cells can be maintained in vitro almost indefinitely, and the long-term cultured cells exhibit robust multi-lineage reconsti-
tutionwhen transferred into irradiatedmice. These cells can be cloned and re-expandedwith 50%plating efficiency, indicating that virtu-
ally all cells are self-renewing. Equivalent progenitors were produced from human cord blood stem cells, and these will ultimately be
useful as a source of cells for immune cell therapy.INTRODUCTION
Somatic tissues with high turnover rates, such as skin,
intestinal epithelium, and hematopoietic cells, are main-
tained by the activity of self-renewing stem cells, which
are present in only limited numbers in each organ
(Barker et al., 2012; Copley et al., 2012; Fuchs and
Chen, 2013). For example, the frequency of hematopoi-
etic stem cells (HSCs) in the mouse is about 1 in 105 of
total bone marrow (BM) cells (Spangrude et al., 1988).
Once HSCs begin the differentiation process, their prog-
eny cells have hardly any self-renewal capacity, indi-
cating that self-renewal is a special feature endowed
only to stem cells.
Cells such as embryonic stem (ES) cells that retain self-
renewal potential and multipotency only in vitro can
also be included in the category of stem cells. Such stem-
ness of ES cells is thought to be maintained by formation
of a core transcriptional network and an epigenetic
status unique to ES cells (Lund et al., 2012; Meissner,
2010; Ng and Surani, 2011). A stem cell equivalent to
ES cells, called induced pluripotent stem (iPS) cells, can
be produced from somatic cells by overexpression of
only a few specific transcription factors (OCT3/4,
SOX2, KLF4, and C-MYC), which are thought to be the
essential components in forming the core network of
transcriptional factors that define the status of ES cells716 Stem Cell Reports j Vol. 5 j 716–727 j November 10, 2015 j ª2015 The(Takahashi et al., 2007; Takahashi and Yamanaka, 2006;
Yamanaka, 2012). It is thus generally conceived that
acquisition of such a network for a somatic cell depends
on the reprogramming of the epigenetic status of that
cell.
On the other hand, it could be envisioned that the
self-renewing status of cells represents a state in which
their further differentiation is inhibited. It is known, for
example, that to maintain ES/iPS cells, factors such as leu-
kemia inhibitory factor and basic fibroblast growth factor,
for mouse and human cultures, respectively (Williams
et al., 1988; Xu et al., 2005), are required, and these fac-
tors are thought to block further differentiation of the
cells. In this context, it has previously been shown that
systemic disruption of transcription factors essential for
the B cell lineage, such as PAX5, E2A, and EBF1, leads to
the emergence of self-renewing multipotent hematopoiet-
ic progenitors, which can be maintained under specific
culture conditions (Ikawa et al., 2004a; Nutt et al., 1999;
Pongubala et al., 2008). It has recently been shown that
the suppression of lymphoid lineage priming promotes
the expansion of both mouse and human hematopoietic
progenitors (Mercer et al., 2011; van Galen et al., 2014).
Therefore, it would seem theoretically possible to make
a stem cell by inducing inactivation of these factors at
particular developmental stages. Conditional depletion
of PAX5 in B cell lineage committed progenitors, as wellAuthors
as mature B cells, resulted in the generation of T cells from
the B lineage cells (Cobaleda et al., 2007; Nutt et al., 1999;
Rolink et al., 1999). These studies, however, were mainly
focused on the occurrence of cell-fate conversion by de-
differentiation of target cells. Therefore, the minimal
requirement for the acquisition of self-renewal potential
remains undetermined.
Our ultimate goal is to obtain sufficient number of
stem cells by expansion to overcome the limitation of
cell numbers for immune therapies. We hypothesize
that stem cells can be produced by simply blocking
differentiation. As mentioned earlier, self-renewing
multipotent progenitors (MPPs) can be produced by
culturing E2A-deficient hematopoietic progenitors in B
cell-inducing conditions (Ikawa et al., 2004a). Because
it remains unclear at which developmental stage the
acquisition of self-renewing potential has occurred in
the case of such a systemic deletion, we thought to
develop a method in which E2A function could be inac-
tivated and reactivated in an inducible manner. We
decided to use the ID3 protein for this purpose, because
it is known that ID proteins serve as dominant-negative
inhibitors of E proteins (Norton et al., 1998; Sayegh
et al., 2003). Here we show that the overexpression of
ID3 into HSCs or hematopoietic progenitor cells
(HPCs) in both mouse and human induces the stemness
of the progenitors and that the cells acquire the self-
renewal activity. The ID3-expressing cells can be main-
tained in vitro as MPPs with T, B, and myeloid lineage
potentials.RESULTS
Generation of ID3-Transduced Hematopoietic
Progenitors
Murine hematopoietic progenitors isolated as LINC-
KIT+SCA-1+ (LKS) cells from the fetal liver (FL) were trans-
duced with a retroviral vector containing Id3 or a control
vector, and the transduced cells were cultured under B
cell-inducing conditions (Figure 1A). The LKS cells trans-
fected with the control vector differentiated into CD19+ B
cells, but the ID3-overexpressing cells showed develop-
mental arrest at the B220lowCD19 stage (Figure 1B). Tran-
script levels of B lineage-associated genes (e.g., Cd79a,
Cd79b, and Vpreb1) in ID3-induced hematopoietic pro-
genitor (IdHP) cells were at least 10-fold lower than
those in control cells (Figure S1A). Instead, the IdHP cells
prominently express genes associated with other lineages
(e.g., Gata3, Gata1, and Cebpa) (Figure S1B). Moreover,
only diversity-joining (D-J) but not variable-DJ(V-DJ) of
immunoglobulin heavy chain (Igh) gene was detectable
in IdHP cells (Figure S1C). These data indicate that theStem Cell RIdHP cells are phenotypically similar to the earliest B cell
progenitors, so-called pre-pro B cells, and are almost indis-
tinguishable from the previously reported E2A-deficient
MPPs (Ikawa et al., 2004a).
The IdHP cells are relatively large blastic cells, morpho-
logically similar to pre-pro B cells (Figures 1C and 1D),
and their gene expression profile is comparable to E2A-defi-
cient progenitors (Figure 1E). The IdHP cells expanded
exponentially, i.e., 103-fold in 1 month (Figure 1F), and
could be maintained for several months or longer. When
transferred to culture conditions inductive for myeloid, B,
or T lineages, the IdHP cells exhibited the potential to
produce all these cell types (Figures 1G–1K); however,
erythroid potential was hardly detected, probably because
the ID3 suppressed not only E2A activity but all E-protein
activities (data not shown).
IdHP Cells Are Multipotent, Maintaining T, B, and
Myeloid Lineage Potentials
We then tested the developmental potential of IdHP cells
in vivo. A total of 1 3 106 IdHP cells (CD45.1)/mouse
were transferred intravenously into sublethally irradiated
RAG1-deficient mice (CD45.2) (Figure 2A). After 4 weeks,
myeloid cells (MAC1+CD19 cells), natural killer (NK)
cells (CD3NK1.1+ cells), and T cells (CD3+NK1.1 cells)
were observed in the CD45.1+ fraction in peripheral
blood of the recipient mice (Figure 2B). A substantial
number of B cells were also detected in these recipients.
In these B cells, downregulated expression of the retro-
viral reporter human CD25 (hCD25) was seen (Figures
S2A and S2B), which often occurs with a retrovirally
introduced gene. The generation of B cells in vitro shown
in Figure 1H could be similarly explained. Such B cell
generation indicates that IdHP cells have the potential
to produce B cells, a clear difference from E2A-deleted
progenitors. T, B, and myeloid cells were generated in
the thymus, spleen, and BM of mice reconstituted with
the IdHP cells at 7 weeks of transplantation (Figures 2C
and 2D). The CD4+ T cells in the spleen generated from
the IdHP cells normally proliferated upon anti-CD3/28
stimulation (Figure 2E), confirming the multilineage
differentiation potential and functionality of the IdHP
cells. To test whether the IdHP cells exhibit self-renewal
activity in vivo, the BM cells in NOD/Shi-scid, IL2Rgnull
(NOG) mice derived from IdHP cells were further
transferred into NOG mice. The mice were analyzed
at 8 weeks of secondary transplantation. The results
demonstrated that the IdHP cells derived from BM cells
exhibited only residual myeloid, but not T and B cell
potential (Figures S2C and S2D). The data ruled out the
possibility that the IdHP cells might contain MPPs
that acquired self-renewal activity or ID3-induced HSC
property in vivo.eports j Vol. 5 j 716–727 j November 10, 2015 j ª2015 The Authors 717
AB
C
D
E F G
H
I J K
Figure 1. Generation of IdHP Cells from Mu-
rine HSCs or HPCs
(A) Schematic representation of IdHP cell
generation.
(B) Flow cytometric analysis of control (empty
vector) and ID3-overexpressing FL progenitor
cells (n = 3).
(C) Photomicrograph of IdHP cells. Scale bar,
10 mm.
(D) Wright’s staining of IdHP cells, LKS cells,
pro B cells, and immature B (Immat B) cells
from BM. Scale bars, 10 mm.
(E) Microarray analysis of gene expression in
LKS cells, E2A/ HPCs, IdHP cells, and pro B
cells derived from cultures of control vector-
expressing FL progenitors.
(F) In vitro expansion of IdHP and control
cells. Viable cells were counted at an each time
point (n = 3).
(G) CFU-C assay of LKS, control, and IdHP cells
(n = 3).
(H) Myeloid and B cell generation from IdHP
cells in vitro. Flow cytometric profiles of IdHP
cells cultured on TSt-4 stromal cells for 14 days
are shown (n = 3).
(I) T cell generation from IdHP cells in vitro.
Flow cytometric profiles of control and IdHP
cells cultured on TSt-4/DLL1 stromal cells for
12 days are shown (n = 3).
(J) The number of MAC1+ cells generated from
IdHP and control cells on TSt-4 stromal cells is
shown (n = 3). The FACS profile from IdHP cells
is shown in (H).
(K) The number of CD4+CD8+ cells generated
from IdHP cells on TSt-4/DLL1 stromal cells
is shown (n = 3). The FACS profiles are shown
in (H) and (I). Student’s t test, *p < 0.05,
***p < 0.001. Data are shown as mean ± SD
from three independent experiments.
See also Figure S1.IdHP Cells Are Multipotent at a Clonal Level
To examine whether IdHP cells retain self-renewal poten-
tial, 96 IdHP cells were individually seeded and cultured
in the same conditions (Figure 3A). Each clone was
expanded with a plating efficiency of 50%. All clones
were able to proliferate unlimitedly like IdHP cells as long
as the cells were properly cultured. Three randomly
selected clones were further expanded, and the cells (1 3
106 cells/mouse) were subsequently transferred into suble-
thally irradiated recipient mice. After 4 weeks, reconstitu-
tion of myeloid cells, B cells, NK cells, and T cells derived
from the transferred cells was observed in the peripheral
blood of these recipients (Figure 3B). Mice transplanted718 Stem Cell Reports j Vol. 5 j 716–727 j November 10, 2015 j ª2015 Thewith clone 1 cells were sacrificed 8 weeks after the transfer,
and cells from the thymus, spleen, and BM were analyzed.
In the BM, MAC1+GR1+ myeloid cells were observed
among the CD45.1+ cells (Figures 3C and 3D). CD45.1+
CD4+CD8+DP cells, as well as CD4SP and CD8SP cells,
were seen in the thymus, and CD45.1+B220+IGM+ mature
B cells were found in the spleen (Figures 3C and 3D). These
data indicate that the production of several lineages of cells
is ongoing in recipient mice. Because IdHP cells are origi-
nally derived from pre-pro B stage cells, they usually bear
at least a single allele of DH-JH rearrangements of the Igh
genes. Clone 1 and 2 had a rearrangement involving the
JH3 gene segment, and all lineage of cells from variousAuthors
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Figure 2. In Vivo Generation of Myeloid, B,
and T Cells from IdHP Cells
(A) Schematic representation of the in vivo
model for investigating the developmental
potential of IdHP cells.
(B) Flow cytometric analysis of cells in
the peripheral blood of mice transplanted
with control or IdHP cells 4 weeks after in-
jection. Donor derived PBMCs (CD45.1+) were
analyzed for the expression of MAC1 versus
CD19 and CD3 versus NK1.1.
(C) Flow cytometric analysis of cells in
thymus, spleen, and BM of mice transplanted
with IdHP cells 7 weeks after injection.
(D) The number of T (CD4+CD8+) cells in
thymus, B (IGM+) cells in spleen, and myeloid
(MAC1+GR1+) cells in BM generated from the
IdHP cells.
(E) CD4+T cells in spleen generated from the
IdHP cells were sorted and labeled with CFSE.
The labeled cells were stimulated with plate-
coated anti-CD3/28 for 4 days. Flow cyto-
metric analysis of the cells after stimulation
is shown (n = 3). ***p < 0.001. Data are
shown as mean ± SD from three independent
experiments.
See also Figure S2.tissues in recipient animals transferred with clone 1 and 2
cells had the same rearrangement (Figures 3E and S3), indi-
cating that all progeny cells were derived from clone 1 and
2, respectively. These results indicate that the IdHP cells
were multipotent at the clonal level.
Generation of IdHP Cells from Mouse BM
To determine whether IdHP cells can also be generated
from adult BM progenitors, the LKS cells in the BM ofStem Cell RB6CD45.1 mice were transduced with a retroviral vector
containing ID3 and the transduced cells were cultured
under B cell-inducing conditions. The IdHP cells were
generated in 1 month, just like the FL-derived IdHP
cells (Figure 4A). The BM-derived IdHP cells exponen-
tially expanded and could be maintained for several
months or longer, similar to the FL-IdHP cells. To deter-
mine the developmental potential of the BM-IdHP cells
in vivo, 1 3 106 IdHP cells/mouse were transplanted intoeports j Vol. 5 j 716–727 j November 10, 2015 j ª2015 The Authors 719
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Figure 3. Lymphoid-Myeloid Lineage
Potential of Single IdHP Cells
(A) Schematic representation of cloning of
IdHP cells and analysis of the developmental
potential of individual IdHP clones.
(B) Generation of lymphoid and myeloid
lineage cells in RAG1/ recipients trans-
planted with cloned IdHP cells. Flow cyto-
metric profiles of donor-type (CD45.1+)
PBMCs 4 weeks after transplantation are
shown.
(C) Analysis of thymus, spleen, and bone
marrow cells in the mice generated in the
experiment shown in (B).
(D) The number of T (CD4+CD8+) cells in
thymus, B (IgM+) cells in spleen, and
myeloid (MAC1+GR1+) cells in BM of
RAG1/ recipients generated in the
experiment (C). Data are shown as mean ±
SD from three independent experiments
(n = 3).
(E) Analysis of Igh D-J rearrangement in the
donor-type (CD45.1+) cells of the thymus,
spleen, and bone marrow of mice used in
experiment (C, and Figure S3) (n = 3).
See also Figure S3.sublethally irradiated immunodeficient (NOG)mice. After
7 weeks, thymic populations, as well as MAC1+GR1+
myeloid cells in the BM, were found to be nicely reconsti-
tuted (Figures 4B and 4C). The CD4+ T cells in the spleen
generated from BM-IdHP cells proliferated and secreted
various cytokines in response to anti-CD3/28 stimulation
in vitro (Figure S4).
To determine from which stage IdHP cells can be gener-
ated, we transfected CD34LKS (HSC), CD34+LKS (MPP),
common lymphoid progenitor (CLP), and common
myeloid progenitor (CMP) cells from the BM with ID3
and control retroviruses. The transfected cells were
cultured on TSt-4 stromal cells in the presence of stem
cell factor (SCF), interleukin-7 (IL-7), and FMS-like tyrosine
kinase 3 ligand (FLT3-L) in a same manner as IdHP cells
from LKS cells. While virtually all control cells from HSC,
MPP, and CLP cells became CD19+ cells after 2 weeks of cul-
ture, the control cells from CMP becamemyeloid cells (Fig-
ure 4D). Id3-transduced cells from HSC and MPP, but not
from other types of progenitors, exhibited similar expan-
sions as IdHP cells from LKS cells. The finding that MPP
cells can generate IdHP cells may indicate that the self-
renewal activity can be endowed to a non-self-renewing
progenitor by ectopic expression of ID3. The failure in
inducing IdHP cells from CLP cells does not necessarily
mean that self-renewal activity is acquired before the CLP720 Stem Cell Reports j Vol. 5 j 716–727 j November 10, 2015 j ª2015 Thestage, because expression of ID3 will take some time after
transfection. These data indicate that the self-renewing
IdHP cells with developmental potential and functionality
similar to those of the FL-IdHP cells can be generated from
adult BM.
Generation of Inducible IdHP Cells Using ID3-ER
Retrovirus
To examine whether IdHP cells are really arrested early in B
cell development, we used the ID3 protein fusedwith estro-
gen receptor, ID3-ER, a more controllable system for the
expression of ID3 inwhich ID3-ER protein normally resides
in the cytoplasm but goes into the nucleus and functions as
a transcriptional inhibitor for E proteins only when 4-hy-
droxytamoxifen (4-OHT) is added (Sayegh et al., 2003).
LKS cells from the FL of B6CD45.1 mice that had been
transduced with the ID3-ER retrovirus and cultured in the
presence of 4-OHT showed a similar developmental arrest
and entered a self-renewal cycle similar to that of IdHP cells
(Figures 5A–5C and S5A–S5D). Removal of 4-OHT did not
have any impact on cell growth for at least 10 days, but
virtually all cells became CD19+ within 7 days (Figure 5D),
indicating that arrested cells restarted differentiation to-
ward B cells upon removal of 4-OHT. These results indicate
that IdHP cells represent cells differentiating toward the B
cell lineage but are arrested just before the B cell lineageAuthors
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Figure 4. In Vivo Generation of Myeloid,
B, and T Cells from BM-Derived IdHP Cells
(A) ID3 and control retroviruses were in-
fected with LKS cells in BM of B6CD45.1
mice, and the infected cells were sorted and
cultured on TSt-4 stromal cells in the pres-
ence of SCF, IL-7, and FLT3-L for 2 weeks.
Flow cytometric profiles of CD19 versus
B220 gated on MAC1GR1NK1.1 cells are
shown.
(B) BM IdHP cells (1 3 106) were intrave-
nously injected into sublethally irradiated
NOG mice. Flow cytometric analysis of cells
in thymus, spleen, and BM of mice trans-
planted with BM IdHP cells 7 weeks after
injection is shown.
(C) The number of T (CD4+CD8+) cells in
thymus, B (IGM+) cells in spleen, and
myeloid (MAC1+GR1+) cells in BM generated
from the IdHP cells (n = 3) is shown. Data
are shown as mean ± SD from three inde-
pendent experiments (n = 3).
(D) Id3 and control viruses were infected
with HSC (CD34LKS), MPP (CD34+LKS), CLP
(LINC-KIT+IL7R+), and CMP (LINC-
KIT+SCA-1CD16/32CD34+) cells in BM of
B6CD45.1 mice, and the infected cells were
sorted and cultured on TSt-4 stromal cells in
the presence of SCF, IL-7, and FLT3-L for
2 weeks. Flow cytometric profiles of CD19
versus B220 gated on MAC1GR1NK1.1
cells are shown.
See also Figure S4.determination step, waiting for appropriate developmental
cues.
To determine the stability of the ID3-ER-transduced
HPCs, the cell-cycle status of fresh (2-month cultured)
and old (10-month cultured) progenitor cells were
analyzed. Although the proportion of cells at G1, S, and
G2/M phases in fresh and old IdHP cells was slightly
different, two histograms showed almost complete overlap
(Figure S5E). These results indicate that the ID3-ER-trans-
duced progenitor cells are stable and can be maintained
without any phenotypic changes for several months or
longer.
Thus, by definition, IdHP cells satisfy the criteria of stem
cells, which are restricted to the production of leukocytes.
We therefore designate these cells as iLS (induced leukocyte
stem) cells as a more general term. The iLS cells are not re-
programmed or de-differentiated but only developmen-
tally arrested. Therefore, we propose that the blockage ofStem Cell Rdifferentiation due to the absence of developmental cues
is sufficient to make stem cells.
Generation of IdHP Cells from Human Cord Blood
Hematopoietic Progenitors
Self-renewing progenitor cells whose development can be
controlled are a potential source for human immune cell
therapy. We therefore attempted to produce human iLS
cells. CD34+ cord blood (CB) cells were transduced with
a retrovirus encoding the human ID3 gene and cultured
under B cell-inducing conditions. In the control vector
group, cells differentiated into CD19+ B cells, although
cells expressing the myeloid marker CD33 were also
generated under this condition (Figure 6A). In the ID3
overexpression group, cells exhibited higher forward or
side scatter properties (Figure 6A), with a larger size and
more cytoplasm (Figure 6B). Just like murine iLS cells,
human iLS cells showed exponential growth for severaleports j Vol. 5 j 716–727 j November 10, 2015 j ª2015 The Authors 721
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Figure 5. Inducible Generation of IdHP
Cells Using an ID3-ER Retrovirus
(A) Developmental potential of FL (LKS)
progenitors transduced with control (ER) and
ID3-ER retrovirus. After transduction, GFP+
cells were sorted and cultured on TSt-4 stro-
mal cells supplemented with SCF, IL-7, and
FLT3-L in the presence or absence of 4-OHT
for 4 weeks. Representative flow cytometric
profiles for CD19 versus B220 are shown.
(B) Expansion of FL (LKS) progenitors trans-
duced with control and ID3-ER retrovirus in
the presence of 4-OHT. Viable cells were
counted at the indicated time points.
(C) Number of LIN cells from control and
ID3-ER infected cells after 32 days of culture.
(D) B cell generation from ID3-ER-transduced
cells after withdrawal of 4-OHT. The per-
centage of CD19+ cells at the indicated time
points is shown. **p < 0.01, ***p < 0.001.
Data are shown as mean ± SD from three
independent experiments.
See also Figure S5.weeks or longer (Figure 6C), although with a slower
growth rate than that of the mouse case. In addition, hu-
man iLS cells exhibited a gene expression pattern similar
to that of murine iLS cells (Figures S1A and S6A). These
human iLS cells retained the potential to give rise to NK
cells and dendritic cells (DCs) or macrophage-like cells
in vitro (Figures 6D and 6E). When transferred into suble-
thally irradiated NOG mice (Figure 6F), human iLS cells
gave rise to B cells (CD19+CD33) and monocytes
(CD33+CD14+) in the BM of the reconstituted mice (Fig-
ures 6G and S6B).DISCUSSION
Identification of cellular and molecular events regulating
self-renewal or differentiation of the cells is a fundamental
issue in the stem cell biology or developmental biology
field. In the present study, we revealed that the simple
inhibition of differentiation in HSCs or HPCs by overex-
pressing ID proteins and culturing them in suitable
conditions induced the self-renewal of hematopoietic
progenitors and allowed the extensive expansion of the
multipotent cells. The reduction of ID proteins in MPPs
resulted in the differentiation of the cells into lymphoid
and myeloid lineage cells. Thus, it is possible to manipu-
late the cell fate by regulating E-protein or ID-protein
activities. This inducible system will be a useful tool to
figure out the genetic and epigenetic program controlling
the self-renewal activity of multipotent stem cells.722 Stem Cell Reports j Vol. 5 j 716–727 j November 10, 2015 j ª2015 ThePrevious studies have shown that hematopoietic pro-
genitors deficient for E2A, EBF1, and PAX5 maintain
multilineage differentiation potential without losing
their self-renewing capacity (Ikawa et al., 2004a; Nutt
et al., 1999; Pongubala et al., 2008), indicating that
the inhibition of the differentiation pathway at certain
developmental stages leads to the expansion of multi-
potent stem cells. However, the MPPs were not able
to differentiate into B cells because they lacked the ac-
tivities of transcription factors essential for the initia-
tion of the B lineage program. In addition, a restriction
point regulating the lineage-specific patterns of gene
expression during B cell specification remained to be
determined because of the lack of an inducible system
that regulates B cell differentiation. Here we have estab-
lished the multipotent iLS cells using ID3-ER retrovirus,
which can be maintained and differentiated into B cells
in an inducible manner by simply adding or with-
drawing 4-OHT. The data indicated the essential role
of E2A for initiation of the B cell program that restricts
other lineage potentials, because the depletion of 4-
OHT from the culture immediately leads to the activa-
tion of E proteins, such as E2A, HEB, and E2-2, that
promote B cell differentiation. This strategy is useful
in understanding the cues regulating the self-renewal
or differentiation of uncommitted progenitors to the
B cell pathway. Analysis of genome-wide gene expres-
sion patterns and histone modifications will determine
the exact mechanisms that underlie the B cell commit-
ment process.Authors
A B
C D E
F G
Figure 6. Generation of IdHP Cells from
Human CB HSCs
(A) Flow cytometric analysis of cells derived
from CD34+ human CB cells transduced with
control and human ID3 retrovirus. After
transduction, GFP+ cells were sorted and
cultured on TSt-4 stromal cells in the pres-
ence of SCF, IL-7, FLT3-L, and thrombo-
poietin (TPO) for 4 weeks.
(B) Wright’s stain of hIdHP and control cells.
Scale bars, 10 mm.
(C) Expansion of hIdHP and control cells on
TSt-4 stromal cells in the presence of human
SCF, IL-7, FLT3-L, and TPO. Viable cells were
counted at the indicated time points (n = 3).
(D and E) NK cell (D) and DC (E) generation
from hIdHP cells in vitro. Flow cytometric
analysis is shown.
(F and G) Generation of CD19+ and CD14+
cells from hIdHP cells in NOG mice. (F)
Schematic representation of the examina-
tion of the developmental potential of
hIdHP cells. (G) Flow cytometric profiles for
CD33 versus CD19 and CD33 versus CD14 of
human CD45+ cell in BM from transplanted
mice. Data are shown from three indepen-
dent experiments.
See also Figure S6.The iLS cells can also be generated from human CB he-
matopoietic progenitors. Human iLS cells exhibited dif-
ferentiation potential and self-renewal activity similar
to those of murine iLS cells, suggesting a similar develop-
mental program during human B cell fate specification.
Our data are consistent with a study demonstrating the
critical role of the activity of ID and E proteins for con-
trolling the status of human HSCs and progenitors (van
Galen et al., 2014). This study reported that the overex-
pression of ID2 in human CB HSCs enhanced theStem Cell Rmyeloid and stem cell program at the expense of
lymphoid commitment. Specifically, ID2 overexpression
resulted in a 10-fold expansion of HSCs, suggesting that
the inhibition of E-protein activities promotes the self-
renewal of HSCs by antagonizing the differentiation.
This raises a question about the functional differences be-
tween ID2 and ID3. Id3 seems to suppress the B cell pro-
gram and promote the myeloid program more efficiently
than does ID2, because the ID2-expressing HPCs appear
to retain more B cell potential than ID3-expressing iLSeports j Vol. 5 j 716–727 j November 10, 2015 j ª2015 The Authors 723
cells (Mercer et al., 2011; van Galen et al., 2014). The self-
renewal activity and differentiation potential of ID2-
HPCs derived from murine HSCs in the BM seemed to
be limited both in vivo and in vitro analysis (Mercer
et al., 2011). In our study, the iLS cells retained more
myeloid potential and self-renewal capacity during the
culture. Strikingly, the multipotent iLS cells enormously
proliferated (>103-fold in 1 month) as long as the cells
were cultured in undifferentiated conditions. This could
be due to the functional differences among Id family
genes. Alternatively, combination with additional envi-
ronmental signals, such as cytokines or chemokines,
may affect the functional differences of ID proteins,
although any ID proteins can repress the activation of
the E2A targets, such as Ebf1 and Foxo1, that are essential
for B cell differentiation. ID1 and ID3, but not ID2, are
demonstrated to be negative regulators of the generation
of hematopoietic progenitors from human pluripotent
stem cells (Hong et al., 2011). Further analysis is required
to determine the physiological role of ID proteins in
regulating hematopoietic cell fate. It also remains to be
determined whether the ID3-ER system can be applied
to human progenitors. It would be informative to
compare the regulatory networks that control B cell dif-
ferentiation in mouse and human.
Immune cell therapy has become a major field of
interest in the last two decades. However, the required
high cell numbers restrain the application and success
of immune reconstitution or anti-cancer treatment. For
example, DCs are already being used in cell therapy
against tumors. One of the major limitations of DC vac-
cine therapy is the difficulty in obtaining sufficient cell
numbers, because DCs do not proliferate in the currently
used systems. The method of making iLS cells could be
applied to such cell therapies. Taken together, the
simplicity of this method and the high expansion rate
and retention of multilineage potential of the cells make
this cell source appealing for regenerative medicine or
immune cell therapy.
In summary, we showed that an artificially induced
block of differentiation in uncommitted progenitors is
sufficient to produce multipotent stem cells that retain
self-renewal activity. Once the differentiation block is
released, the cells start differentiating into mature cells
both in vivo and in vitro. Thus, this method could be
applicable for establishing somatic stem cells from
other organs in a similar manner, which would be quite
useful for regenerative medicine. The relative ease of
making stem cells leads us to conceive that a block in
differentiation is essential not only in other types of ar-
tificially engineered stem cells, such as ES cells and iPS
cells, but also in any type of physiological somatic stem
cell. In this context, it is tempting to speculate that it724 Stem Cell Reports j Vol. 5 j 716–727 j November 10, 2015 j ª2015 Thecould have been easy for a multicellular organism to
establish somatic stem cells by this mechanism during
evolution.EXPERIMENTAL PROCEDURES
Mice
C57BL/6 (B6) and B6CD45.1 mice were purchased from CLEA
Japan. NOD/Shi-scid, IL2Rgnull (NOG) mice were purchased from
the Central Institute for Experimental Animals. We used 6- to 8-
week-old female mice for the transfer experiments. Embryos at
various stages of gestation were obtained from timed pregnancies.
The day of observing the vaginal plug was designated as 0 dpc.
Animal and human experiments were approved by the RIKEN
Institutional Animal Care and Use and Human Subjects Use
Committees, respectively.
Antibodies
The following antibodies were purchased fromBDBiosciences: fluo-
rescein isothiocyanate (FITC)-conjugated erythroid lineage cells
(TER119: 561032), MAC1 (553310), GR1 (553127), CD11C
(557400), B220 (553088), THY1.2 (553004), CD8A (553031), CD4
(553651), NK1.1 (553164), CD3ε (553062), CD19 (553785), TCRgd
(553177), phycoerythrin (PE)-conjugated SCA-1 (553336), CD4
(553653), CD19 (553786), GR1 (553128), NK1.1 (553165), TCRb
(553172), human CD11C (347637), human CD25 (555432), hu-
man CD33 (555450), allophycocyanin (APC)-conjugated CD45.1
(558701), CD45.2 (558702), C-KIT (553556), CD19 (550992), hu-
man CD19 (555415), human CD56 (555518) and human HLA-DR
(559866). FITC-IGM (11-5790-81) was purchased from eBioscience.
TER119, MAC1, GR1, B220, CD19, NK1.1, CD3ε, CD4, and CD8A
were used as Lin markers.
Growth Factors
Recombinant murine (rm) SCF, IL-1a, IL-3, IL-7, IL-15, FLT3-L, G-
CSF, M-CSF, and GM-CSF and recombinant human (rh) SCF, IL-7,
IL-15, FLT3-L, GM-CSF and TNFa were purchased from R&D
Systems.
Isolation of Hematopoietic Progenitors
Single cell suspensions of FL cells from 13 to 15 dpc embryos or BM
cells of B6CD45.1 mice were prepared as described previously
(Ikawa et al., 2004b). Cells were then incubated withmAbs specific
for anti-lineage markers (TER119, MAC1, GR1, B220, and THY1.2)
for 20 min on ice. Lin+ cells were depleted with Dynabeads
Sheep anti-Rat IgG (Invitrogen) according to the manufacturer’s
protocol. The LIN cells were used for cell sorting. The procedure
for isolating LINSCA-1+C-KIT+ (LKS) populations from the FL
and BM and isolating pro B cells (IGMB220+CD19+CD43+) and
immature B (IGM+B220+CD19+) cells from BM has been described
elsewhere (Ikawa et al., 2004a, 2004b).
Retroviral Constructs, Viral Supernatants, and
Transduction
The TAC retroviral vector (pCSretTAC) is based on the S-001 retro-
virus construct (obtained from H. Spits) and was generated byAuthors
replacing the coding sequence of EGFP with the human IL2RA
gene encoding CD25. The full-length cDNA for murine Id3 was
cloned into the pCSretTAC vector (mID3-TAC). The ID3-ERT2
fusion construct containing the full-length cDNA for human
ID3 fused to the mutated ligand-binding domain of the human
estrogen receptor (ERT2) was cloned into the pMCS retrovirus
vector (a gift from T. Kitamura). The human ID3 cDNAwas cloned
into the pMX retrovirus construct (obtained from T. Kitamura).
Virus was generated by transfection of the various constructs
into the Plat E packaging cell line using the FuGENE 6 Transfec-
tion Reagent (Roche). For generating mouse IdHP (mIdHP) cells,
FL LKS progenitors from B6LY5.1 mice (CD45.1+) were isolated
as described earlier. The LKS cells were transduced with pCSret-
TAC (control) andmID3-TAC virus supernatants as described pre-
viously (Sayegh et al., 2003). After spin infection, the cells were
cultured at 37C, 5% CO2 for 2 days. The transduced cells were
harvested and stained with anti-human (h)CD25 antibody,
and the hCD25+ cells were sorted and cultured on TSt-4 stromal
cells in the presence of 10 ng each of rmSCF, rmIL-7, and
rmFLT3-L. In the case of hIdHP cells, CD34+ cells in hCB cells
were used as a source of progenitors. Human CD34+ cells were
transduced with pMX-hID3 retrovirus in a same manner as the
mIdHP cells. After 2 days, the GFP+ cells were isolated and
cultured on TSt-4 stromal cells in the presence of rhSCF, rhTPO,
rhIL-7, and rhFLT3-L.In Vitro Differentiation Culture System
To assess granulocyte/macrophage potential of mIdHP cells,
10,000 cells per well were cultured with TSt-4 stromal cells in
the presence of rmG-CSF (10 ng/ml) for 14 days. Generated cells
were counted, stained with MAC1, and FACS-sorted MAC1+ cells
were centrifuged onto glass slides for Wright staining. For the
detection of the B and myeloid potential of progenitors, mIdHP
cells were cultured with TSt-4 cells for 14 days. Generation of
myeloid and B cells was detected by flow cytometric analysis
of MAC1 versus CD19 expression. For the detection of T cell po-
tential, TSt-4 cells that had been retrovirally transduced with the
murine dll-1 gene (TSt-4/DLL1 cells) (Ikawa et al., 2010) were
used. Medium was supplemented with rmSCF (2 ng/ml), rmIL-
7 (2 ng/ml), and rmFLT3-L (2 ng/ml). Generation of T cells
was detected by subsequent flow cytometric analysis. To assess
the NK and DC potential of hIdHP cells, 10,000 cells were
cultured with TSt-4 cells in the presence of rhIL-15 (for NK cells)
or rhSCF, rhGM-CSF, and rhTNFa (for DCs). All co-cultures were
maintained in RPMI 1640 medium (Gibco-BRL) supplemented
with 10% FCS, L-glutamine (2 mM), sodium pyruvate (1 mM),
sodium bicarbonate (2 mg/ml), nonessential amino acid solu-
tion (0.1 mM) (Gibco-BRL), 2-ME (5 3 105 M), streptomycin
(100 mg/ml), and penicillin (100 U/ml).Cloning of mIdHP Cells
Single mIdHP cells were seeded on TSt-4 cells in the presence of
SCF, IL-7, and FLT3-L in a 96-well plate. The colonies of single
mIdHP cells were picked up and expanded in the same condition
in larger plates for approximately 4 weeks. The clonedmIdHP cells
were harvested, stained with specific markers, and analyzed by
flow cytometer.Stem Cell RColony-Forming Unit in Culture Assay
LKS, control, and IdHP cells (10,000 cells per dish) were cultured in
triplicate for 7 days in a-MEM (Gibco-BRL) containing 30% FCS,
1% methylcellulose, 1% BSA, 2-ME (5 3 105 M), L-glutamine
(1 mM), rmSCF (10 ng/ml), rmIL-3 (10 ng/ml), rmGM-CSF
(10 ng/ml), rmIL-1a (10 ng/ml), rmG-CSF (10 ng/ml), and rmM-
CSF (10 ng/ml).
Cell Cycle Assay
Cells (1 3 106) cells were washed with PBS twice and treated them
with ice-cold 70% ethanol at 4C for 2 hr. The cells then were
washed with PBS twice and incubated with 1 ml of RNase solution
(0.25 mg/ml) at 37C for 60 min. Propidium iodide (Sigma) were
added to the cell suspension (final concentration: 50 mg/ml) and
incubated at 4C for 30 min. The cells were analyzed by flow
cytometer.
Adoptive Transfer of mIdHP and hIdHP Cells
For mIdHP transfer, 1 3 106 mIdHP cells (CD45.1+) were intrave-
nously injected into the tail vain of sublethally irradiated (650
rad) RAG1-deficient mice (CD45.2). These mice were analyzed
4–6 weeks after reconstitution for donor chimerism in BM,
spleen, and thymus. For hIdHP transfer, 1 3 106 hIdHP cells
were intravenously injected into the tail vain of sublethally
irradiated (240 rad) NOG mice. These mice were analyzed
6–10 weeks after reconstitution for donor chimerism in BM,
spleen, and thymus.
PCR Analysis of Igh Gene Rearrangement
The analysis of Igh gene rearrangement was performed as previ-
ously described (Ikawa et al., 2004a). In brief, genomic DNA
was prepared from CD45.1+ cells derived from thymus, spleen,
and BM in IdHP-transplanted mice using the DNeasy tissue kit
(QIAGEN). The reaction volume was 20 ml, containing 2 ml of
genomic DNA (approximately equivalent to 104 cells), 2 ml of
10x PCR buffer, 0.16 ml of 25 mM dNTPs, 4 pmol of each primer,
and 0.6 U of Taq polymerase (GE Healthcare). The PCR reactions
were performed as follows: 5 min at 94C followed by 35 cycles
of 1 min at 94C, 1 min at 60C, 2 min at 72C, and finally
10 min at 72C. Amplified DNA products were analyzed on an
agarose gel followed by ethidium bromide staining.
RNA Extraction and qRT-PCR
Total RNA was isolated using an RNeasy kit (QIAGEN). cDNA
synthesis was performed using Superscript III (Invitrogen)
following the manufacturer’s protocol. Real-time PCR was per-
formed using SYBR Premix EX Taq (Takara) and analyzed by
StepOnePlus (Applied Biosystems). The reactions were per-
formed in duplicate at 95C for 10 s, followed by 40 cycles of
95C for 5 s and 55C for 30 s. The primer sequences used are
shown in Table S1.
Microarray Analysis
RNA extraction was performed as described earlier. The expres-
sion profiles were analyzed using the 3D-Gene Mouse Oligo
chip 24K (Toray Industries). The fluorescence intensities wereeports j Vol. 5 j 716–727 j November 10, 2015 j ª2015 The Authors 725
detected using the Scan-Array Lite Scanner (PerkinElmer). The
photomultiplier tube levels were adjusted to achieve 0.1%–0.5%
pixel saturation. Each TIFF image was analyzed using the Gene
Pix Pro ver. 6.0 software (Molecular Devices). The data were
filtered to remove low-confidence measurements and were glob-
ally normalized per array such that themedian of the signal inten-
sity was adjusted to 50 after normalization (accession number:
GSE46158).SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and one table and
can be found with this article online at http://dx.doi.org/10.
1016/j.stemcr.2015.09.012.
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